Sort
64,565 grants matching “drug discovery”
Development and validation of a high-throughput MicroED-driven platform technology for natural product discovery
$555,090Cassandra Leah Quave · Emory University · R01 · FY2025 · AT
Structure and dynamics of G protein coupled receptor-G protein complexes
$555,034Brian K Kobilka · Stanford University · R01 · FY2015 · GM
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment
$554,970Weidong Wang · University Of Alabama At Birmingham · R01 · FY2025 · DK
Project 2
$554,965Michael Benatar · University Of Miami School Of Medicine · U54 · FY2015 · NS
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi
$554,959Li Li · Case Western Reserve University · U01 · FY2016 · CA
Targeting HIV cell-to-cell transmission
$554,946Walther H Mothes · Yale University · R01 · FY2012 · AI
Discovery and validation of drug resistance mutations
$554,926Eric H. Rubin · Harvard Medical School · U19 · FY2014 · AI
Deconstructing Cartilage Mechanotransduction by Piezo Channels
$554,806Farshid Guilak · Washington University · R01 · FY2022 · AR
Small Molecule Therapeutic for Heart Failure
$554,801Sathyamangla V Prasad · Cleveland Clinic Lerner Com-Cwru · R61 · FY2025 · HL
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease
$554,778Chunyu Wang · Rensselaer Polytechnic Institute · R01 · FY2024 · AG
Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment
$554,760Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2025 · AI
Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment
$554,760Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2023 · AI
Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment
$554,760Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2021 · AI
Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment
$554,760Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2024 · AI
Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment
$554,760Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2022 · AI
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers
$554,744Henning Willers · Massachusetts General Hospital · U01 · FY2022 · CA
Photon-counting X-ray and Optical Tomography for Preclinical Cancer Research
$554,732Ge Wang · Rensselaer Polytechnic Institute · R01 · FY2020 · CA
Studies of Retinopathy of AIDS in the HAART Era
$554,720University Of California San Diego · R01 · FY2005 · EY
Targeting neuroinflammation in AD with novel CX3CR1 agonists
$554,644Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG
Late Transition Metal Catalysts for Organic Synthesis
$554,637Stephen L Buchwald · Massachusetts Institute Of Technology · R01 · FY2015 · GM
Late Transition Metal Catalysts for Organic Synthesis
$554,637Stephen L Buchwald · Massachusetts Institute Of Technology · R01 · FY2014 · GM
POST-TRANSCRIPTIONALLY ACTING ALZHEIMER'S DRUGS
$554,624Message Pharmaceuticals, Inc. · R44 · FY2001 · AG
Anti-folate chemotype protein degraders
$554,605James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Antisense oligonucleotide treatment for myotonic dystrophy
$554,543Charles A Thornton · University Of Rochester · U01 · FY2011 · NS
Multiomic profiling of cell types mediating opioid use disorder in rats
$554,504Francesca Telese · University Of California, San Diego · R01 · FY2022 · DA